At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02367 GIANT BIOGENE
Trading 07-22 10:12:30
28.600
-0.340
-1.17%
High29.000Low28.380Vol1.16M
Open29.000D1 Closing28.940Amplitude2.14%
Mkt Cap30.37BTradable Cap30.37BTotal Shares1.06B
T/O33.01MT/O Rate0.11%Tradable Shares1.06B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Jefferies Adjusts Giant Biogene's Price Target to HK$32 From HK$35, Keeps at Hold
MT Newswires Live  ·  07-20 12:46
Jefferies Adjusts Giant Biogene's Price Target to HK$32 From HK$35, Keeps at Hold
Movement Alert｜Giant Biogene Falls 5.27% in Regular Trading, Trading at HK$27.92
Market Focus  ·  07-17
Movement Alert｜Giant Biogene Falls 5.27% in Regular Trading, Trading at HK$27.92
Movement Alert｜Giant Biogene Rises 5.13% in Regular Trading, Medical Aesthetics Product Matrix Accelerates Commercialization as Institutions Eye Fundamental Inflection Point
Market Focus  ·  07-16
Movement Alert｜Giant Biogene Rises 5.13% in Regular Trading, Medical Aesthetics Product Matrix Accelerates Commercialization as Institutions Eye Fundamental Inflection Point
Movement Alert｜Giant Biogene Rises 5.28% in Regular Trading, Medical Aesthetics Matrix Accelerates as Institutions See Inflection Point
Market Focus  ·  07-15
Movement Alert｜Giant Biogene Rises 5.28% in Regular Trading, Medical Aesthetics Matrix Accelerates as Institutions See Inflection Point
Giant Biogene Shares Surge Over 6% in Session on Medical Aesthetics Expansion and Fading Regulatory Concerns
Stock News  ·  07-10
Giant Biogene Shares Surge Over 6% in Session on Medical Aesthetics Expansion and Fading Regulatory Concerns
Movement Alert｜Giant Biogene Rises 5.08% in Regular Trading, Medical Aesthetics Dual Certification and Strong 618 Performance Drive Rebound
Market Focus  ·  07-10
Movement Alert｜Giant Biogene Rises 5.08% in Regular Trading, Medical Aesthetics Dual Certification and Strong 618 Performance Drive Rebound
Movement Alert｜Giant Biogene Rises 6.43% in Regular Trading, 618 Promotion Results Beat Expectations Amid Sector-Wide Strength
Market Focus  ·  06-29
Movement Alert｜Giant Biogene Rises 6.43% in Regular Trading, 618 Promotion Results Beat Expectations Amid Sector-Wide Strength
Movement Alert｜Giant Biogene Falls 5.18% in Regular Trading, Profit-Taking After Prior Session Surge Amid Consumer Sector Valuation Pressure
Market Focus  ·  06-25
Movement Alert｜Giant Biogene Falls 5.18% in Regular Trading, Profit-Taking After Prior Session Surge Amid Consumer Sector Valuation Pressure
Giant Biogene Shares Surge Over 6% in Early Trading, CICC Reiterates Outperform Rating
Deep News  ·  06-24
Giant Biogene Shares Surge Over 6% in Early Trading, CICC Reiterates Outperform Rating
Movement Alert｜Giant Biogene Rises 5.45% in Regular Trading, Crosslinked Recombinant Collagen Implant Approval Boosts Market Confidence
Market Focus  ·  06-24
Movement Alert｜Giant Biogene Rises 5.45% in Regular Trading, Crosslinked Recombinant Collagen Implant Approval Boosts Market Confidence
Giant Biogene Shares Surge Over 4% Intraday Following Approval of Key Medical Device
Stock News  ·  06-24
Giant Biogene Shares Surge Over 4% Intraday Following Approval of Key Medical Device
CICC Maintains "Outperform Industry" Rating on Giant Biogene, Adjusts Target Price to HK$40
Stock News  ·  06-22
CICC Maintains "Outperform Industry" Rating on Giant Biogene, Adjusts Target Price to HK$40
Hong Kong Market Announcement Highlights: Three IPOs Launch Including Optical Module Supplier, Lenovo Plans $2 Billion Convertible Bond Issue
Stock News  ·  06-18
Hong Kong Market Announcement Highlights: Three IPOs Launch Including Optical Module Supplier, Lenovo Plans $2 Billion Convertible Bond Issue
Giant Biogene Unit Gets Registration Certificate for Neck Wrinkle Injection
MT Newswires Live  ·  06-17
Giant Biogene Unit Gets Registration Certificate for Neck Wrinkle Injection
Giant Biogene Secures NMPA Approval for World’s First Cross-linked Recombinant Type III Collagen Neck Filler
Bulletin Express  ·  06-17
Giant Biogene Secures NMPA Approval for World’s First Cross-linked Recombinant Type III Collagen Neck Filler
Giant Biogene Secures Medical Device Registration for Its Cross-Linked Recombinant Collagen Implant
Stock News  ·  06-17
Giant Biogene Secures Medical Device Registration for Its Cross-Linked Recombinant Collagen Implant
Giant Biogene Holding Co Ltd - Certificate Issued by China National Medical Products Administration
THOMSON REUTERS  ·  06-17
Giant Biogene Holding Co Ltd - Certificate Issued by China National Medical Products Administration
Giant Biogene Holding Co - Receives China Medical Device Registration for Cross-Linked Recombinant Collagen Implant
THOMSON REUTERS  ·  06-17
Giant Biogene Holding Co - Receives China Medical Device Registration for Cross-Linked Recombinant Collagen Implant
Giant Biogene wins China NMPA approval for neck-wrinkle recombinant collagen filler
Reuters  ·  06-17
Giant Biogene wins China NMPA approval for neck-wrinkle recombinant collagen filler
Assessing Giant Biogene Holding (SEHK:2367) Valuation After Approving Final And Special Dividends
Simply Wall St.  ·  06-09
Assessing Giant Biogene Holding (SEHK:2367) Valuation After Approving Final And Special Dividends

Introduction

Company Name.
GIANT BIOGENE
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Giant Biogene Holding Co Ltd is an investment holding company primarily engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include professional skin treatment products such as functional skincare products and medical dressings, as well as functional foods and others. The Company primarily conducts its businesses in domestic market.
Issue price:
--